Overview

A Study to Compare the Effectiveness of Two Anti-HIV Drug Combinations

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare two different anti-HIV drug combinations, one that contains nelfinavir (NFV) and one that does not. The best dosing schedule for indinavir (IDV) also will be studied.
Phase:
N/A
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Indinavir
Lamivudine
Nelfinavir
Stavudine